[1]Prusier S B. Prions. Proceedings of the National Academy of Sciences of the United States of America, 1998, 95(23): 13363-13383.[2]Aguzzi A, Heikenwalder M. Pathogenesis of prion disease: current status and future outlook. Nature Reviews Microbiology, 2006, 4(10): 765-775.[3]朱采红, 俞国华, 李 蓓, 陈建泉,成国祥. 哺乳动物Prion病研究新进展. 中国人兽共患病学报, 2007, 23(11): 1156-1159.Zhu C H, Yu G H, Li B, Chen J Q, Cheng G X. Progress in mammal Prion disease research. Chinese Journal of Zoonoses, 2007, 23(11): 1156-1159. (in Chinese)[4]Horiuchi M, Karino A, Furuoka H, Ishiguro N, Kimura K, Shinagawa M. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity. Virology, 2009, 394: 200-207.[5]Cordes H, Bergstrom A L, Ohm J, Laursen H, Heegaard P M. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues. Journal of Immunological Methods, 2008, 337: 106-120.[6]Aguzzi A, Glatzel M. Prion infections,blood and transfusions. Nature Clinical Practice Neurology, 2006, 2(6):321-329.[7]俞国华, 刘思国, 成国祥. 蛋白质:生物界中又一类信息的储存者和传递者. 生物化学与生物物理进展, 2005, 32(8): 1-9. Yu G H, Liu S G, Cheng G X. Protein-based storage and transmission of biological information: the Reinterpretation of prion biology. Progress in Biochemistry and Biophysics, 2005, 32(8):1-9. (in Chinese)[8]Prusiner S B, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang S L, Dearmond S J. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proceedings of the National Academy of Sciences of the United States of America, 1993, 90:10608-10612.[9]Krasemann S, Groschup M H, Harmeyer S, Hunsmann G, Bodemer W. Generation of monoclonal antibodies againest human prion proteins in PrP 0/0 mice. Molecular Medicine, 1996, 2(6):725-734.[10]Denning C, Burl S, Ainslie A, Bracken J, Dinnyes A, Fletcher J, King T, Richie M, Richie W A, Rollo M, Sousa P, Travers A, Willmut I, Clark A J. Deletion of the alpha (1,3) galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheep. Nature Biotechnology, 2001, 19:559-562.[11]Kuroiwa Y, Kasinathan P, Matsushita H, Sathiyaselan J, Sullivan E J, Kakitani M, Tomizuka K, Ishida I, Robl J M. Sequential targeting of the genes encoding immunoglobulin -mu and prion protein in cattle. Nature Genetics, 2004, 36(7): 775-780.[12]Richt J A, Kasinathan P, Hamir A N, Castilla J, Satiyaseelan T, Vargas F, Satiyaseelan J, Wu H, Matsushita H, Koster J, Kato S, Ishida I, Soto C, Robl J M, Kuroiwa Y. Production of cattle lacking prion protein. Nature Biotechnology, 2007, 25(1):132-138.[13]Yu G H, Chen J Q, Yu H Q, Liu S G, Chen J, Xu X J, Sha H Y, Zhang X F, Wu G X, Xu S F, Cheng G X. Functional disruption of prion protein gene in cloned goats. Journal of General Virology, 2006, 87(Pt4): 1019-1027.[14]Zhu C, Li B, Yu G H, Chen J Q, Yu H Q, , Chen J Wu Y, Zhang A M, Cheng G X. Production of Prnp-/- goat by gene targeting in adult fibroblasts. Transgenic Research, 2009, 18(2)163-171.[15]朱采红, 俞国华, 李 蓓, 许媛媛, 俞慧清, 陈建泉, 钱 旻, 成国祥. 利用启动子缺陷型打靶载体敲除牛胎儿成纤维细胞中的Prnp. 生物工程学报, 2008, 24(11): 1988-1992.Zhu C H, Li B, Yu G H, Xu Y Y, Yu H Q, Chen J Q, Cheng G X. Targeting Prnp in bovine fibroblasts by promoter-trap strategy. Chinese Journal of Biotechnology, 2008, 24(11): 1988-1992. (in Chinese)[16]Yu G H, Chen J Q, Xu Y Y , Zhu C H , Liu S G, Sha H Y, Chen J , Xu X , Wu Y, Zhang A, Ma J, Cheng G X. Generation of gaots lacking prion protein. Molecular Biology Reports, 2009, 76(1): 3[17]王志亮, 吴晓东, 刘雨田, 邹艳丽, 鲍恩东, 王长杰. 单抗介导牛海绵状脑病免疫组化检测方法的建立及其应用. 中国农业科学, 2005, 38(4): 634-638.Wang Z L, Wu X D, Liu Y T, Zou Y L, Bao E D, Wang C J. Establishment of monoclonal antibody-based immunohistochemistry assay for detection of bovine spongiform encephalopathy (BSE) and it’s application. Scientia Agricultura Sinica, 2005, 38(4): 634-638. (in Chinese)[18]张永强, 吴晓东, 刘雨田, 张海涛, 王志亮, 鲍恩东. 小尾寒羊瘙痒病单抗制备及免疫组化检测方法的初步建立. 中国农业科学, 2006, 39(4): 819-824.Zhang Y Q, Wu X D, Liu Y T, Zhang H T, Wang Z L, Bao E D. Establishment of the method of immunohistochemistry assay for the detection of scrapie by monoclonal antibody. Scientia Agricultura Sinica, 2006, 39(4): 819-824.(in Chinese)[19]Wu X D, Wang Z L, Y T Liu, Zhang Y Q, Chen Y P, Zou Y L. Development of mAb-based immunohistochemistry method for BSE surveillance in China. Annals of The New York Academy of Sciences, 2006, 1081:112-113.[20]袁志栋, 王志亮, 刘雨田, 吴晓东, 赵永刚, 刘海生. 水牛朊蛋白成熟片段基因的克隆与原核表达. 中国农业科学, 2006, 39(12): 2590-2596.Yuan Z D, Wang Z L, Liu Y T, Wu X D, Zhao Y G, Liu H S. Cloning, prokaryotic expression of the buffalo mature PrP gene. Scientia Agricultura Sinica, 2006, 39(12): 2590-2596. (in Chinese)[21]Hayashi H K, Yokoyama T, Takata M, Iwamaru Y, Imamura M, Ushiki Y K, Shinagawa M. The N-terminal cleavage site of PrPSc f rom BSE differs from that of PrPSc from scrapie. Biochemical and Biophysical Research Communications, 2005, 328(4): 1024-1027.[22]Polymenidou M, Moos R, Scott M, Sigurdson C, Shi Y Z, Yajima B, Brathkovic I H, Jerala R, Hornemann S, Wuthich K, Bellon A, Very M, Garen G, Michael N, Kav N, Aguzzi A. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prionprotein epitopes. PLoS One, 2008, 3: e3872.[23]Muller-Schiffmann A, Korth C. Vaccine approaches to prevent and treat prion infection: progress and challengs. BioDrugs, 2008, 22(1):45-52.[24]White A R, Enever P, Tayebi M, Mushens R, Linehan J, Brander S, Anstee D, Collinge J, Hawke S. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature, 2003, 422: 80-83.[25]Alexandrenne C, Hanoux V, Dkhissi F, Boquet D, Couraud J, Wijkhuisen A. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies. Journal of Neuroimmunology, 2009, 209(1-2): 45-52.[26]Sakaguchi S, Ishibashi D, Matsuda H. Antibody-based immunoyherapeutic attempts in experimental animal models of prion diseases. Expert Opinion on Therapeutic Patents, 2009, 19(7): 907-917.[27]Tayebi M, Collinge J, Hawke S. Unswitched immunoglobulin M response prolongs mouse survival in prion disease. Journal of General Virology, 2009, 90: 777-782.[28]Chung E, Ji Y, Sun Y J, Kascsak R J, Kascsak R B, Metha P D, Strittmatter S M, Wisniewski T. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer’s disease model mouse. BMC Neuroscience, 2010, 11:130-141. |